.........................No adverse events reported from that trial so far, so hopefully CHM have got the CarT vs solid tumor problem solved................
CHM's Car-T therapy success against solid tumors would put CHM ahead of the pack and open up its medical treatment to an unbelievably huge market. Couldn't imagine what the SP could do but assume big pharma wouldn't allow CHM to separately license its therapy without an immediate T/O.
Elimination of chemo and radiation would be gladly welcomed by all patients and I would hope the whole medical profession.
CHM Price at posting:
31.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)